SCHEMBL22854976

SCHEMBL22854976

c1ccc(-c2ccc3oc4ccc(-c5c6ccccc6c(-c6ccccc6-c6ccccc6)c6ccccc56)cc4c3c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G2A P14555 4/20 0.46
PLA2G4A P47712 4/20 0.46
PLA2G10 O15496 1/20 0.40
KDM4E B2RXH2 2/20 0.38
MEN1 O00255 2/20 0.38
MAPT P10636 2/20 0.38
KMT2A Q03164 2/20 0.38
PIM1 P11309 1/20 0.38
CSNK2A2 P19784 1/20 0.38
CSNK2B P67870 1/20 0.38
PIM3 Q86V86 1/20 0.38
PIM2 Q9P1W9 1/20 0.38
NPC1 O15118 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
PRKDC P78527 3/20 0.37
PGR P06401 1/20 0.37
HSP90AA1 P07900 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21450854 0.97 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10KDM4EMEN1
SCHEMBL24285566 0.95 PLA2G2A (0.44) PLA2G2APLA2G4APLA2G10KDM4EMEN1
SCHEMBL27011631 0.94 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10KDM4EMEN1
SCHEMBL26404353 0.94 PLA2G2A (0.42) PLA2G2APLA2G4APLA2G10KDM4EMEN1
SCHEMBL25624663 0.94 PLA2G2A (0.45) PLA2G2APLA2G4APLA2G10KDM4EMEN1
SCHEMBL25624664 0.94 PLA2G2A (0.45) PLA2G2APLA2G4APLA2G10KDM4EMEN1
SCHEMBL10038659 0.94 PLA2G2A (0.47) PLA2G2APLA2G4APLA2G10KDM4EMEN1
SCHEMBL125907 0.94 NPC1 (0.45) PLA2G2APLA2G4APLA2G10KDM4EMEN1
SCHEMBL22854993 0.93 PLA2G2A (0.44) PLA2G2APLA2G4APLA2G10KDM4EMEN1
SCHEMBL10038660 0.93 PLA2G2A (0.47) PLA2G2APLA2G4APLA2G10KDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024096410-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2024-05-10 WO disclosed
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-01-18 US disclosed
US-20230320214-A1 ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND LG CHEM, LTD. (KR) 2023-10-05 US disclosed
US-20230292609-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2023-09-14 US disclosed
US-20230292609-A1 ORGANIC LIGHT EMITTING DEVICE LG CHEM, LTD. (KR) 2023-09-14 US disclosed
US-20200411771-A1 ORGANIC LIGHT-EMITTING DEVICE LG CHEM, LTD. (KR) 2020-12-31 US disclosed
US-20160326086-A1 4-HYDROXYBUTYRIC ACID ANALOGS SUN PHARMACEUTICAL INDUSTRIES, INC. 2016-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE EED, EML4, ESR1 PLA2G2A 3402/4885PLA2G4A 4288/4885PLA2G10 3755/4885
US-20160326086-A1 4-HYDROXYBUTYRIC ACID ANALOGS HCRTR2, HCRTR1, HTR2B PLA2G2A 3051/4885PLA2G4A 1741/4885PLA2G10 2403/4885
US-20230320214-A1 ORGANIC LIGHT-EMITTING DEVICE INCLUDING ORGANIC COMPOUND CYP1A1, AOX1, CYP1B1 PLA2G2A 4379/4885PLA2G4A 4323/4885PLA2G10 4328/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.